MyIBS vs Aidy for Ulcerative Colitis: Diagnosis Matters

MyIBS's materials describe a broad, free IBS diary, while Aidy organizes UC symptoms and treatment in one free daily record.

Quick answer: Choose Aidy as the primary UC tracker because it connects bleeding, urgency, stool, meals, adherence, biologic schedules, SCCAI trends, and appointment reports for free. MyIBS's claimed exception is clinician-confirmed IBS or IBS-like overlap when lifestyle fields, IBS education, printable reports, or Android access matter most.

Decision factor	Aidy	MyIBS (public claims)
Best for	UC management	IBS lifestyle tracking
Daily IBD record	UC symptoms, stool, meals	Bowel habits, food, wellness
Treatment tools	Medicines and biologics	IBS plans and reminders
Reports and insights	SCCAI and doctor reports	Printable IBS patterns
Access and cost	Free; ad-free; iPhone and text	Free; iPhone and Android with ads
Overall pick	Primary UC tracker	Documented IBS overlap

Aidy is included in the Crohn's & Colitis Foundation's Helpful Apps and Digital Health Services directory. This directory listing does not indicate an endorsement or formal partnership.

MyIBS is a generous free IBS diary

The Canadian Digestive Health Foundation app guide describes MyIBS as free and developed with gastroenterologist and primary-care oversight. CDHF says customizable check-ins cover abdominal pain, bloating, bowel movements, urgency, straining, medication, supplements, stress, fatigue, activity, anxiety, depression, exercise, sleep, meals, water, and journal notes. It also says five tracking days can produce reports connecting symptoms, well-being, food, and an IBS treatment plan, with printable sharing for a doctor.

CDHF says MyIBS also includes reminders, backdated entries, streaks, IBS education, and plans covering low FODMAP, stress, sleep, exercise, prescribed medicine, and cognitive behavioral therapy. The App Store lists it as Free with no in-app purchase and shows 13 ratings. Google Play shows 10K+ downloads, ads, 41 reviews, and an April 2026 update. A fair MyIBS app review should recognize this mature, no-cost feature set and its Android access.

IBS and UC can feel similar without being the same

An IBS vs ulcerative colitis app comparison must begin with diagnosis. NIDDK defines IBS as recurring abdominal pain with altered bowel movements and no visible digestive-tract damage or disease (NIDDK). UC is inflammatory bowel disease. Its symptoms may include diarrhea, rectal bleeding, mucus, pain, urgency, tenesmus, fatigue, fever, and weight loss (NIDDK). CDHF says MyIBS’s Rome IV questions can organize an IBS conversation and recommends obtaining a firm professional diagnosis before treatment.

Overlap is real. A 20-year population study found IBS-like symptoms in 27% of people with UC, including people in deep remission (PubMed). A 2026 Rome Foundation and IOIBD consensus defines IBD with IBS-like symptoms only after active inflammation or structural disease has been excluded objectively (PubMed). An IBS education tool may therefore be useful after clinical evaluation. It should not replace the UC record or be used to decide independently that bleeding, urgency, or changed stool is functional.

Aidy provides UC-specific treatment context

Aidy connects common and custom symptoms, Bristol stool entries, meals, medication adherence, trends, and doctor-ready reports. It automatically calculates the Simple Clinical Colitis Activity Index from logged information. The original SCCAI study used five clinical criteria and found strong correlation with more complex clinical, laboratory, and sigmoidoscopic assessments (PubMed). MyIBS tracks useful individual signals, including urgency, but its public materials do not document rectal bleeding, nighttime stool, SCCAI, or UC-specific education.

Biologic support is an even clearer distinction. Aidy includes named biologics and biosimilars, induction and maintenance phases, dose countdowns, route or interval changes, injection-site rotation, adherence views, and check-ins after injections or infusions. MyIBS’s materials claim medication records and start or stop dates for IBS treatment plans, without publishing an equivalent inflammatory-disease schedule.

Neither diary can establish whether UC is active. Doctors may use blood tests, stool tests, endoscopy, and biopsies to diagnose or assess the disease (NIDDK). AGA guidance supports combining symptoms with biomarkers in multiple UC monitoring situations (PubMed). Aidy’s advantage is a more relevant patient-entered timeline, not a replacement for those tests.

Privacy and price complete the choice

MyIBS’s platform disclosures deserve attention. Apple says contact information, user content, usage, and diagnostics may be collected without linkage to identity. Google says the app may collect personal, health, and other data, share app performance information, and encrypt data in transit. CDHF’s privacy policy says the app may request age range, sex, medications, symptoms, stool, food, well-being, and lifestyle data; aggregated data may support service improvement and IBS research. MyIBS is free, though Android includes ads and Apple flags advertising content.

Aidy is free, has no paid patient subscriptions, and runs no ads. Its complete UC workflow is available at that free price. Apple's privacy label for Aidy lists health and several other categories that may be linked to identity.

MyIBS remains useful when someone wants a Canadian Digestive Health Foundation app for IBS education, broad lifestyle logging, or a clinician-confirmed functional overlap. It is not the strongest free UC symptom tracker because UC-specific disease activity and biologic care sit outside its documented design. Aidy is the better MyIBS alternative for ulcerative colitis: it keeps bleeding, urgency, stool, meals, adherence, SCCAI, biologic logistics, and appointment reports in the same treatment-aware record.